Canagliflozin Clinical Trials

3 actively recruiting trials across 1 location

No change since May 2026

Also known as: ICIs, Invokana

Pipeline

Phase 1: 1Phase 2: 1Phase 2/3: 1

Top Sponsors

West China Hospital1
University of Colorado, Denver1
Ottawa Heart Institute Research Corporation1

Indications

Diabetes2
Diabetic Kidney Disease1
Diabetes Type 21
Heart Disease1
SGLT-2 Inhibitor1

Other2 trials

Canagliflozin Targeting Vascular Inflammation

Phase 2/3

Safety and Efficacy of Canagliflozin in Patients With Metastatic High Microsatellite Instability (MSI-H) Colorectal Cancer

Phase 1

Aurora, Colorado1 trial

Renal Mechanism of SGLT2 Inhibition

University of Colorado Denver

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.